VEDBAEK, Denmark, October 1 — – Announcement No. 40/2008 – To OMX Nordic Exchange Copenhagen and the Press. Exiqon A/S today announces a grant of license to Roche Diagnostics for use of the Universal ProbeLibrary that is based on Exiqon’s proprietary LNA(TM) detection technology. Roche Diagnostics will develop its new product line for RealTime ready […]
BioTrove, Inc. today announced the launch of Pathways pre-validated qPCR assay panels, the latest addition to the OpenArray(TM) Real-Time qPCR System. These standardized panels contain a pre-determined set of optimized, validated assays, allowing researchers to skip the initial steps of gene selection and assay optimization, and begin immediate work on the analyses of commonly studied […]
Sequenom, Inc. (Nasdaq: SQNM) today announced that it has secured exclusive rights to fundamental patent rights for digital PCR technologies and methods through a licensing agreement with Genomic Nanosystems, LLC, a wholly owned subsidiary of the Cytonix Corporation. The exclusively licensed rights include United States Patent Nos. 6,143,496 and 6,391,559 and pending applications. The license […]
Names Nine Service Providers, Broadening Access to TaqMan® Assays for a Wide Range of Sample Processing and Data-Analysis Applications FOSTER CITY, Calif.–Applied Biosystems Inc. (NYSE:ABI) today announced that it has established a global service provider program for RNA expression analysis. The TaqMan® Service Provider Program was created for research scientists who do not have laboratories […]
NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and sample preparation systems, and the Hamilton Company, a world leader in precision liquid handling announced today the two companies have assembled an automated, total target preparation solution to address the high-throughput challenges required in processing large sets of clinical samples […]
Sequenom, Inc. (Nasdaq: SQNM), a leading provider of genetic-analysis solutions, today announced that it has acquired exclusive worldwide rights (excluding Hong Kong) to digital PCR and other noninvasive prenatal diagnostic intellectual property from The Chinese University of Hong Kong. These newly acquired rights expand Sequenom’s existing, broad intellectual property portfolio of noninvasive prenatal diagnostic methods […]
Company Executes Licenses with Three Leading Life Science Companies CARLSBAD, Calif.–Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard & Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen’s patented technology […]
PENZBERG, Germany–A fast, flexible, and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by PCR, RT-PCR, sequencing, arrays etc. In addition, automation of nucleic acid isolation is becoming increasingly important for reproducibility and to reduce experimental error. During the last years, demands regarding hardware design, software, and […]
August 19, 2008 08:00 AM Eastern Daylight Time PENZBERG, Germany–A fast, flexible, and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by PCR, RT-PCR, sequencing, arrays etc. In addition, automation of nucleic acid isolation is becoming increasingly important for reproducibility and to reduce experimental error. During the […]
Patents in this agreement targeting rapid polymerase chain reaction and High Resolution Melting on Corbett’s Rotor-Gene instruments Venlo, The Netherlands and Salt Lake City, UT, August 4, 2008 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) and Idaho Technology, Inc. are pleased to announce that the companies have reached a settlement agreement for rights […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
